A Phase II Trial to Assess the Effect of Cinacalcet Hydrochloride on PSA Levels in Patients With Biochemically Recurrent Prostate Cancer After Failed Definitive Local Therapy.
Latest Information Update: 08 Nov 2021
At a glance
- Drugs Cinacalcet (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
- 10 Apr 2018 Status changed from active, no longer recruiting to completed.
- 31 Jan 2013 Planned end date changed from 1 Jan 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov.
- 17 Apr 2012 Planned end date changed from 1 Sep 2015 to 1 Jan 2013 as reported by ClinicalTrials.gov.